mitomycin has been researched along with butylhydroxybutylnitrosamine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (70.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukushima, S; Inoue, K; Ito, N; Ohtaguro, K; Okamura, T | 1 |
| Kawano, S; Ogata, J; Sakamoto, S; Yano, S | 1 |
| Okamura, T | 1 |
| Fukushima, S; Ito, N; Koiso, K; Niijima, T; Ohtani, M | 1 |
| Fujita, J; Ito, Y; Tokuda, H; Yoshida, O | 1 |
| Fukushima, S; Ito, N; Koiso, K; Niijima, T; Ohtani, M; Okamura, T; Sakata, T | 1 |
| Miyakawa, M; Yoshida, O | 1 |
| Bilensoy, E; Erdogar, N; Eroglu, H; İskit, AB; Mungan, NA; Sargon, MF | 1 |
| Fujimoto, K; Hori, S; Miyake, M; Morizawa, Y; Nakai, Y; Onishi, S; Tanaka, N; Tatsumi, Y | 1 |
| Fujimoto, K; Gotoh, D; Hori, S; Iida, K; Itami, Y; Miyake, M; Morizawa, Y; Nakai, Y; Onishi, K; Onishi, S; Tanaka, N; Tatsumi, Y | 1 |
10 other study(ies) available for mitomycin and butylhydroxybutylnitrosamine
| Article | Year |
|---|---|
[Effect of intravesical instillation of the antitumor chemotherapeutic agents mitomycin C and cytosine arabinoside on rat bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl) nitrosamine].
Topics: Administration, Intravesical; Animals; Antineoplastic Combined Chemotherapy Protocols; Butylhydroxybutylnitrosamine; Cytarabine; Female; Mitomycin; Mitomycins; Rats; Rats, Inbred F344; Urinary Bladder Neoplasms | 1987 |
Effect of continuous intravesical infusion of low-concentrated mitomycin-C on bladder carcinogenesis in rats treated with N-butyl-N-4-hydroxybutyl-nitrosamine.
Topics: Administration, Intravesical; Animals; Butylhydroxybutylnitrosamine; Carcinoma, Papillary; Carcinoma, Transitional Cell; Catheters, Indwelling; Male; Mitomycin; Mitomycins; Rats; Rats, Inbred Strains; Time Factors; Urinary Bladder Neoplasms | 1988 |
[Effect of intrabladder instillation of various anticancer agents on carcinogenesis in rat bladder].
Topics: Administration, Intravesical; Animals; Antineoplastic Agents; Butylhydroxybutylnitrosamine; Doxorubicin; Female; Hyperplasia; Mitomycin; Mitomycins; Rats; Rats, Inbred F344; Urinary Bladder; Urinary Bladder Neoplasms | 1988 |
Effects of intravesical instillation of antitumor drugs on the induction of preneoplastic bladder lesions in rats.
Topics: Animals; Butylhydroxybutylnitrosamine; Doxorubicin; Female; Hyperplasia; Mitomycin; Mitomycins; Precancerous Conditions; Rats; Rats, Inbred F344; Urinary Bladder Neoplasms | 1983 |
Therapeutic effect of a retinoid (Ro 10-9359) on rats with bladder tumours induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine upon administration alone or in combination with mitomycin C.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Butylhydroxybutylnitrosamine; Drug Administration Schedule; Etretinate; Female; Mitomycin; Mitomycins; Rats; Rats, Inbred Strains; Urinary Bladder Neoplasms | 1983 |
Effects of intravesical instillation of antitumor chemotherapeutic agents on bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Topics: Animals; Antineoplastic Agents; Butylhydroxybutylnitrosamine; Doxorubicin; Drug Synergism; Female; Hyperplasia; Mitomycin; Mitomycins; Nitrosamines; Papilloma; Precancerous Conditions; Rats; Rats, Inbred F344; Urinary Bladder Neoplasms | 1984 |
[Effect of cis-diamminedichloroplatinum (II) (CDDP) on bladder cancer on rats induced by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN)].
Topics: Animals; Butylhydroxybutylnitrosamine; Cisplatin; Cyclophosphamide; Female; Mitomycin; Mitomycins; Neoplasms, Experimental; Nitrosamines; Organ Size; Rats; Rats, Inbred Strains; Urinary Bladder Neoplasms | 1982 |
Cationic core-shell nanoparticles for intravesical chemotherapy in tumor-induced rat model: safety and efficacy.
Topics: Administration, Intravesical; Animals; Antibiotics, Antineoplastic; Butylhydroxybutylnitrosamine; Cations; Chitosan; Disease-Free Survival; Drug Carriers; Kaplan-Meier Estimate; Male; Mitomycin; Nanoparticles; Polyesters; Rats, Sprague-Dawley; Urinary Bladder; Urinary Bladder Neoplasms | 2014 |
Topical and systemic immunoreaction triggered by intravesical chemotherapy in an N-butyl-N-(4-hydroxybutyl) nitorosamine induced bladder cancer mouse model.
Topics: Adjuvants, Immunologic; Administration, Intravesical; Animals; Antineoplastic Combined Chemotherapy Protocols; Butylhydroxybutylnitrosamine; Cytokines; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Mice; Mitomycin; Neoplasms, Experimental; Treatment Outcome; Urinary Bladder Neoplasms | 2017 |
Intravesical treatment of chemotherapeutic agents sensitizes bacillus Calmette‑Guerin by the modulation of the tumor immune environment.
Topics: Administration, Intravesical; Animals; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Butylhydroxybutylnitrosamine; Carcinoma, Transitional Cell; Disease Progression; Doxorubicin; Female; Humans; Killer Cells, Natural; Macrophages; Mice, Inbred C57BL; Mitomycin; Neoplasm Recurrence, Local; Neoplasms, Experimental; T-Lymphocytes, Regulatory; Treatment Outcome; Tumor Microenvironment; Urinary Bladder; Urinary Bladder Neoplasms | 2019 |